Extens and Innovation Capital finance a €3.6M round to accelerate Kayentis’ international growth

Back Published on 10/10/2016

Kayentis, a global provider of electronic Clinical Outcome Assessment (eCOA) solutions for patient and data collection in clinical trials, today announced the completion of a €3.6M growth financing round.

Kayentis’ experience of over 120 clinical trials 75 countries (6,000 sites and 50,000 patients), and in a broad range of therapeutic areas, has shown its added value to data quality and clinical trial efficiency with innovative and intuitive solutions, and two development priorities: Patient Engagement and Risk-based Monitoring.

The funds raised will enable Kayentis to accelerate its growth internationally and to position itself as a leading global provider of eCOA solutions.

« Thanks to its range of solutions and quality of service, Kayentis has become a partner of choice in the industry of clinical trials. The company’s strong development in the last two years validates our decision to happily reinvest in this round with the aim of making Kayentis a worldwide major eCOA player. »